Batavia Biosciences is a biopharmaceutical CDMO with extensive experience in virus vaccine, viral vector, microbial vaccine, recombinant protein and monoclonal antibody projects. The company offers their novel technologies and in depth know how in order to help our partners to complete preclinical phases in biopharmaceutical product development at higher speed, reduced cost and increased success.
The company offers services including mammalian cell line generation, upstream and downstream process development (mammalian & microbial), analytical development and clinical GMP manufacturing. Headquartered in Leiden, The Netherlands, with a US-based facility in Woburn, Massachusetts, and offices in Hong Kong, Batavia Biosciences is privileged to have strong strategic partners worldwide.
Jun 28, 2022
Posted by Batavia Biosciences